{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:14:50Z","timestamp":1758946490891},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T00:00:00Z","timestamp":1379635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00277-013-1904-0","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T05:05:38Z","timestamp":1379567138000},"page":"883-884","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness of bosentan in a case of pulmonary arterial hypertension associated with myelodysplastic syndrome"],"prefix":"10.1007","volume":"93","author":[{"given":"Antonio Luis","family":"G\u00e1mez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Luis","family":"Bonilla-Palomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirian","family":"Moreno-Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Cristina","family":"L\u00f3pez-Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Villar-R\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,20]]},"reference":[{"issue":"6","key":"1904_CR1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0761-8425(09)74695-9","volume":"26","author":"C Lamour","year":"2009","unstructured":"Lamour C, Bergeron A (2009) Non-infectious pulmonary complications of myelodysplastic syndromes and chronic myeloproliferative disorders. Rev Mal Respir 26(6):655\u2013665","journal-title":"Rev Mal Respir"},{"issue":"3","key":"1904_CR2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1378\/chest.120.3.801","volume":"120","author":"D Dingli","year":"2001","unstructured":"Dingli D, Utz JP, Krowka MJ, Oberg AL, Tefferi A (2001) Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest 120(3):801\u2013808","journal-title":"Chest"},{"issue":"2","key":"1904_CR3","first-page":"245","volume":"89","author":"V Garypidou","year":"2004","unstructured":"Garypidou V, Vakalopoulou S, Dimitriadis D, Tziomalos K, Sfikas G, Perifanis V (2004) Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders. Haematologica 89(2):245\u2013246","journal-title":"Haematologica"},{"issue":"2","key":"1904_CR4","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1378\/chest.103.2.642","volume":"103","author":"KS Marvin","year":"1993","unstructured":"Marvin KS, Spellberg RD (1993) Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia. Chest 103(2):642\u2013644","journal-title":"Chest"},{"issue":"7","key":"1904_CR5","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1182\/blood-2012-04-422568","volume":"120","author":"A Anthi","year":"2012","unstructured":"Anthi A, Tsangaris I, Hamodraka ES, Lekakis J, Armaganidis A, Orfanos SE (2012) Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension. Blood 120(7):1531\u20131532","journal-title":"Blood"},{"issue":"2","key":"1904_CR6","first-page":"105","volume":"78","author":"M Correale","year":"2012","unstructured":"Correale M, De Rosa F, Ieva R, Di Biase M, Brunetti ND (2012) Long-term treatment with high-dose of sildenafil in a thalassemic patient with pulmonary hypertension. Monaldi Arch Chest Dis 78(2):105\u2013106","journal-title":"Monaldi Arch Chest Dis"},{"issue":"3","key":"1904_CR7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.2010.08097.x","volume":"149","author":"RJ Barst","year":"2010","unstructured":"Barst RJ, Mubarak KK, Machado RF, Ataga KI, Benza RL, Castro O, Naeije R, Sood N, Swerdlow PS, Hildesheim M, Gladwin MT (2010) Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies. Br J Haematol 149(3):426\u2013435","journal-title":"Br J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1904-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1904-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1904-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T05:49:46Z","timestamp":1559022586000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1904-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,20]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["1904"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1904-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,20]]}}}